Moranoline (1 -deoxynojirimycin) isolated from mulberry root bark (Mori Cortex), is a potent intestinal a-glucosidase inhibitor. The IC50 values for sucrase and maltase in various animals ranged around 10~7m.Postprandial hyperglycemia in sucrose-, starch-, or maltose-loaded rats was significantly supressed by simultaneous administration of moranoline in doses over 6 mg/kg. In contrast to the potent inhibition of intestinal a-glucosidase, the inhibition of /?-glucosidase, glucoamylase, and a-amylase was weak.
sembles moranoline, only weakly inhibited a-glucosidase but strongly inhibited^-glucosidase.
Postprandial hyperglycemia in diabetic patients can be avoided only with strict dietary control. Non-enzymatic glycosylation of various plasma and tissue proteins proceeds actively during periods of hyperglycemia. The dysfunction of these glycosylated proteins seems to be the cause of manyof the lesions which develop gradually in patients with diabetes mellitus.1}
A new approach to prevent postprandial hyperglycemia may emerge from the therapeutic use of a-amylase or a-glycosidase inhibitors.2)
In the course of screening for inhibitors of intestinal a-glucosidase, 1-deoxynojimycin, designated "moranoline,'' has been isolated from Mori Cortex (root bark of the mulberry tree),3'4) leaves of Jacobinia suberecta,5) and a culture filtrate of Streptomyces species.6) This compoundwas obtained from Nojirimycin7) by catalytic degradation.8) Soon after the first finding of moranoline in nature by Murai et al., 3) two other research groups, Frommer et al. and Murao and Miyata, isolated this compound independently from the culture filtrate of a Bacillus species,9' 10) and a Streptomyces Species,Xl) respectively.
This paper describes the inhibition by mora- noline12) and its N-alkyl derivatives13) of glucosidase activity and of the postprandial rise of blood glucose. 
MATERIALS AND METHODS

Chemicals
-Deoxynojirimycin:
Synthesis of N-substituted alkyl derivatives of moranoline. While a number of procedures are available for synthesizing the contemplated compounds of this study, the commonest procedure is alkylation of the corresponding N-norcompound, moranoline.
This alkylation, in turn, may be done by various alternative procedures, for example by reacting moranoline with an alkyl halide, by N-acylating moranoline and then reducing the N-acyl derivative to the N-alkyl compound,and by reductive alkylation using a carbonyl compound.It is also advantageous to start with moranoline having suitably protected hydroxyl groups such as benzyl, benzoyl, or acetyl, in which case the N-alkylation reaction is followed by removal of the protective groups.
The following examples are intended to further describe the methodby which the compoundsof this study are produced. methanol, mp 198~199°C, [a£4+ 12.2°(methanol) . N-Propyl derivative; l.O g of benzyl derivative of moranoline (mp 44~47°C) is dissolved in 50ml ofDMF, then 3.0g of anhydrous potassium carbonate and 2.0g of propyl bromide are added. The mixture is stirred with heating at 60+ 3°C for 12hr, after which it is diluted with water and extracted with benzene. The extract is dissolved in a mixture of 10ml of47% hydrobromic acid and 7ml of acetic acid, then heated at 100°C for one hour. After cooling, 100ml of methanol is added into the reaction mixture, and the solution is hydrogenated over 300mg of 5% palladium-charcoal.
After Intestinal a-glucosidases (a-D-glucosidase, EC 3.2. 1.20) were prepared by the method ofTakesue15) or ofKolinska and Kraml.16) The small intestines of various animals were rinsed in cold saline, the mucosawas scraped off and homogenized with 5 volumes of 0.5m NaCl-0.5M KC1-5him EDTA (pH 7.0) using a Polytoron® (Kinematica). The homogenate was centrifuged at 60,000 x g for 60 min, the supernatant was discarded, and the sediment was washed with 10mM potassium phosphate buffer (pH 7.4) and centrifuged again. The sediment was incubated with 10mMpotassium phosphate buffer (pH 7.0) containing 0.01% papain and cysteine for 60min at 37°C. After papain treatment, the 105,000 xg (60min) supernatant was fractionated with ammoniumsulfate (45~60%satu-ration). The dialyzed precipitate was used for the assay. Disaccharidase activity was measured by the method of Dahlqvist.17 zU£/C (min-mg/dl)= l/2 [{a+b)-tl+(b+c)-t2+ à" å à"} a,b,c, à"à" à" , differences of blood glucose levels between initial time and the indicated time (a=0) tlt t2, ' à" à", differences between two consecutive times
RESULTS
Intestinal a-glucosidase inhibition by moranoline Specific activities of partially purified intestinal a-glucosidases are shown in Table I . Maltase activity was higher than sucrase activity in all the species or strains tested. Rats and rabbits had higher maltase and sucrase activities than any of the other animals. The concentrations of moranoline needed for 50% inhibition (IC50) of various intestinal a-glucosidases are shown in Table II. IC50 values were 6.6^16x10 8m and 7.46 3x10~8m for sucrase and maltase, respectively.
Effects ofmoranoline on blood glucose levels in carbohydrate-loaded ra ts Figure 2 shows the effects of moranoline on No toxic symptomincluding diarrhea was observed at the doses tested here.
Glucosidase inhibitory and hypoglycemic activities of N-alkyI derivatives of moranoline Table III shows the enzyme inhibitory and hypoglycemic activities of the various N-alkyl derivatives of moranoline (1) as well as of nojirimycin and DMDP.Potent inhibition of rabbit intestinal sucrase and maltase was observed with the compounds in which the carbon numbers of the alkyl chain were less than 13; among them, (1) and N-methylmoranoline (2) were the most active. The higher N-alkyl derivatives (12, 13) were less active. Nojirimycin and its stable derivative, bisulfite, were comparably inhibitory to moranoline derivatives. DMDP was far less active. Inhibition of AAUC for up to 180min at a dose of 10 mg/kg of each compound was calculated when sucrose (2 g/kg) was given orally to To confirm their inhibitory action in vivo, the hypoglycemic action of these compounds was examined in sucrose-, maltose-, or starchloaded rats. The rise of,blood glucose levels in carbohydrate-loaded rats was significantly suppressed by the simultaneous administration ofmoranoline in a dose of 10mg/kg. In a dose of 20 mg/kg of moranoline, the blood glucose levels were higher than those of the control at later stages (120min or 180min) though the peak height was lower than that of the control. This phenomenon might be explained by the reduction of the amount of moranoline in the intestine with time. Because moranoline is an absorbable compound (unpublished data), the inhibitory action of intestinal a-glucosidases may not continue for a long time. It is estimated that the hydrolysis of undigested maltose or sucrose lowers the blood glucose peak at the later stages. At a higher dose of moranoline (60 mg/kg), the blood glucose peak did not appear up to 180min. It was shown that the a-glucosidase inhibitor, moranoline, can completely suppress postprandial hyperglycemia in starch-loaded animals without a-amylase inhibition.
The results of this study prove the critical importance of intestinal aglucosidases in starch digestion. To obtain more potent compounds, N-alkyl derivatives of moranoline were synthesized. Nmethyl (2) and N-ethyl (3) derivatives were more potent inhibitors of postprandial hyperglycemia in sucrose-loaded rats. Structurally similar nojirimycin and DMDP had different inhibitory patterns from those of moranoline and its N-alkyl derivatives against a-or /?-glucosidases or glucoamylase.
